Trial intelligence / Profile preview

CONQUEST: Pantoprazole in GERD

NCT00449813Phase 4Terminated

Sponsor
Takeda
Start
Mar 2007
Primary completion
Oct 2007
Modality
Small Molecules
Countries
2
01

Overview

A Phase 4 trial of pantoprazole in gastroesophageal reflux disease (GERD), sponsored by Takeda. Started Mar 2007; status: terminated.

02

Drugs

pantoprazole
03

Conditions

gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on NCT00449813.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00449813.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call